Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

Clinical trial NCT02673398 · COMPLETED

Trial details

NCT number: NCT02673398
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2 Positive Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7

Start date: 2016-12-02
Primary completion: 2020-03-12
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.